{
  "id": 16941487,
  "title": "Challenges and recommendations for implementation of oncology clinical practice guidelines in China",
  "url": "https://urgent.news/2026/10/28/challenges-and-recommendations-for-implementation-of-oncology",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-28T14:00:00.000Z",
  "source": {
    "name": "PLOS Medicine",
    "slug": "plos-medicine",
    "url": "https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1005261"
  },
  "original_language": "en",
  "account": "China faces a growing cancer burden and complex treatment landscape, making clinical practice guidelines (CPGs) essential for standardising cancer care and aiding clinical decision-making. In recent decades, China has made significant strides in developing oncology CPGs, shifting from relying on expert consensus and adapting international guidelines to producing them domestically.\n\nHowever, the core challenge for oncology CPGs in China lies not in the absence of guidelines themselves, but in the lack of an integrated governance and implementation ecosystem, along with insufficient alignment with local evidence. To address this, this Policy Forum offers a conceptual framework for other transition economies dealing with a mismatch between rapid clinical technology scaling and fragmented regulatory governance.\n\nThe proposed four-part strategic framework consists of:\n\n1. Establishing a national joint clearinghouse and registration system for CPGs.\n2. Integrating resource-stratified pathways with locally relevant evidence.\n3. Expanding free, diversified dissemination channels for CPGs.\n4. Embedding implementation science alongside healthcare financing alignment.\n\nBy tackling these systemic gaps, China can transition from simply expanding clinical guidelines in quantity to adopting a more equity-oriented, system-integrated approach to quality enhancement in cancer care, providing scalable lessons for global health systems aiming to achieve the same goal.",
  "summary": "by Minzhi Lv, Duanduan Yuan, Yue Suo, Fang Ding, Lijuan Hu, Lei Cao, Yi Wang, Jing Lei, Shenglan Tang, Tianshu Liu Summary points As China’s cancer burden continues to rise and treatment becomes increasingly complex, clinical practice guidelines (CPGs) are crucial to standardising cancer care and supporting clinical decision-making. Over the past decades, China has made substantial progress in…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}